Firma BIOTRONIK, Autor bei Presse-Blog

TCT 2017: BIOTRONIK’s Orsiro Drug-Eluting Stent Shows Low Five-Year Event Rates in BIOFLOW-II RCT and BIOFLOW-III Registry

2. November 2017 Firma BIOTRONIKMedizintechnikarm, bioflow, biotronik, clinical, eluting, implant, new, onze, orsiro, patients, registry, stent, study, with, xience

DENVER, United States and BUELACH, Switzerland, November 2, 2017 – BIOTRONIK’s Orsiro1 drug-eluting stent (DES) demonstrated high long-term safety and clinical performance according to 60-month follow-up data presented during TCT 2017. Data from the BIOFLOW-II randomized controlled trial was presented Mehr

TCT 2017: Magmaris Resorbable Magnesium Scaffold (RMS) Continues to Show No Instances of Scaffold Thrombosis

1. November 2017 Firma BIOTRONIKMedizintechnikbiosolve, biotronik, brs, clinical, Coating, eluting, haude, magmaris, novo, patients, plla, scaffold, therapy, vessel, with

Data presented during the TCT congress on BIOTRONIK’s Magmaris1 RMS provide further evidence on its continued safety and efficacy. Pooled 12-month data from the BIOSOLVE-II and BIOSOLVE-III clinical trials highlight high procedural success and the continuous absence of late definite Mehr

TCT 2017: BIOTRONIK Symposium Highlights Differing Roles of Drug-Eluting Stents and Magnesium Scaffolds in Clinical Practice

31. Oktober 2017 Firma BIOTRONIKMedizintechnik

Data presented at the BIOTRONIK-sponsored symposium on the Orsiro1 drug-eluting stent (DES) demonstrate why Orsiro is gaining prominence in the crowded DES market. In addition, clinical and preclinical data presented about Magmaris2 reinforce the case that the magnesium-based resorbable technology Mehr

Gemeinsam viel bewegen innerhalb der Herzwochen zum Thema das „Schwache Herz“

24. Oktober 2017 Firma BIOTRONIKMedizintechnikaeds, app, asb, berlin, biotronik, bvmed, defibrillator, herzfehler, herzstillstand, herztod, icd, kampagne, notruf, schüler, sport

BIOTRONIK und der Arbeiter-Samariter-Bund (ASB) Berlin haben heute anlässlich der bundesweiten im November startenden Herzwochen 2017 ihre Partnerschaft im Engagement gegen den plötzlichen Herztod vorgestellt. Das Berliner Medizintechnikunternehmen und der ASB arbeiten seit Anfang des Jahres im Rahmen der Initiative Mehr

BIOTRONIK Announces First Enrollments to BIOVITESSE Trial

9. Oktober 2017 Firma BIOTRONIKMedizintechnik

BIOTRONIK has announced the start of enrollment of a coronary stent trial aiming at assessing the safety and clinical performance of a new coronary stent in de novo coronary artery lesions. On September 28, first Dr. Marco Moccetti, Cardiocentro Ticino, Mehr

BIOTRONIK CLS Technology Shown to Reduce Fainting in Syncope Patients by Seven-Fold

4. Oktober 20174. Oktober 2017 Firma BIOTRONIKMedizintechnik

BIOTRONIK’s exclusive rate responsive technology, Closed Loop Stimulation (CLS) has shown to reduce fainting in pacemaker patients with vasovagal syncope up to sevenfold. Results from the SPAIN study, the first prospective double-blind placebo-controlled trial, have now been published in the Mehr

CIRSE 2017: BIOTRONIK Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy

18. September 2017 Firma BIOTRONIKMedizintechnik4ever, bailout, bioflex, biolux, biotronik, passeo, patients, Ptx, pulsar, restenosis, scaffold, stent, thin, with, zilver

Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce restenosis rates, according to results from various BIOTRONIK studies presented at the 2017 congress of the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). In-stent Mehr

BIOFLOW-V Studie hat gezeigt: Der ultradünne Medikament-freisetzende „Orsiro“ Stent ist effektiver und sicherer als der „Xience“ Stent

13. September 2017 Firma BIOTRONIKMedizintechnikbioflow, biotronik, diabetes, eluting, energy, esc, freisetzenden, heart, kandzari, orsiro, patienten, pci, stent, Studie, xience

Auf dem diesjährigen Kongress der Europäischen Gesellschaft für Kardiologie (ESC) wurden die BIOFLOW-V Studienergebnisse im Rahmen einer „Hotline Session“ präsentiert und parallel in der Fachzeitschrift The Lancet publiziert. Viele Jahre galt Xience als Goldstandard der DES (Drug Eluting Stent)-Therapie. Die Mehr

European Heart Rhythm Association and BIOTRONIK Mark Ten Years of Collaboration with EHRA White Book 2017 Analysis

29. August 2017 Firma BIOTRONIKMedizintechnik

The European Heart Rhythm Association (EHRA) released the analytical supplement to the 10th EHRA White Book during the ESC Congress 2017 in Barcelona. Supported by BIOTRONIK, the EHRA White Book is the annual collection of data about the number of Mehr

CASTLE-AF Study Results Indicate Catheter Ablation of Atrial Fibrillation as First-Line Treatment for Heart Failure Patients

28. August 201728. August 2017 Firma BIOTRONIKMedizintechnikablation, atrial, biotronik, catheter, clinical, crt, esc, fibrillation, heart, icd, measures, patients, study, treatment, with

Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause mortality and hospitalization for worsening heart failure, when heart failure patients with atrial fibrillation (AF) are treated with catheter ablation, compared to pharmacological therapy Mehr

Autor: Firma BIOTRONIK